Your browser does not support java script. Skip navigation
Loading, please wait  Loading, please wait...
 
 

SCSHP Fall Meeting 2020 (Pharmacy Technicians) - (Online)


SCSHP 2020 Fall Meeting
Wednesday, October 7 - 9, 2020
 
To register and view the full meeting agenda, visit: 
 
Individual registration for the South Carolina Society of Health-System Pharmacists (SCSHP) Fall Meeting (https://scshp.com/meet-reg1.php?id=1) is required to claim CPE credit.  ANY credit claimed by individuals who did not register for the meeting will be reversed from the CPE Monitor.
 
Location:  Virtual Conference
 
For all continuing education session details, including speakers and learning objectives, please expand the individual sessions below!  

Date: Oct 7, 2020 04:00 PM - Oct 9, 2020 08:00 PM

CE Hours

9.50

CE Units

0.950

Activity Type

  • Knowledge-Based and Application-Based

Target Audience(s)

  • Pharmacy Technicians

Accreditation(s)

Accreditation Council for Pharmacy Education
The University of South Carolina College of Pharmacy is accredited by the Accreditation Council for Pharmacy Education as a provider of continuing pharmacy education.

Co-Sponsor(s)

SCSHP

Requirements for CE Credit

Participants must sign in upon arrival and have attendance verified.
 
To claim credit for this activity, participants must complete the online program evaluation and must update their accounts to properly reflect their month/day of birth and correct NABP e-Profile ID.  To register with NABP or look up your NABP e-Profile ID, please click on the CPE Monitor logo below to be directed to their site. 
 
Credit that is claimed greater than 60 days from the date of the program will be automatically rejected by the CPE Monitor.  Claiming credit within 30 days of the live program will ensure that any issues with transmission to the CPE Monitor can be rectified in advance of the 60-day deadline.  If you would like a paper statement of credit, you may print an individual statement or a transcript from your NABP e-Profile.
 

 

 

 

 

At the completion of this activity, the participant will be able to:
  1. Describe pharmacist impact on commonly encountered clinical scenarios
  2. Provide an example of appropriate continuity of care for commonly encountered clinical scenarios
  3. Apply medication safety principles to commonly encountered clinical scenarios
  4. Describe the importance of applying evidence-based medicine to commonly encountered clinical scenarios

Speaker(s)/Author(s)

Kathy Chessman, PharmD, BCPS, BCNSP, FCCP
Professor, Medical University of SC College of Pharmacy

Activity Number

0062-9999-20-198-L01-T
Date: 10/07/20
Time: 04:00 PM - 05:30 PM

CE Hours

1.50
 

 

 

At the completion of this activity, the participant will be able to:
  1. Describe how COVID-19 causes disease and respiratory symptoms in patients
  2. Discuss basic preventative measures and why they are important to reduce the spread of COVID-19
  3. Examine evidence for Vitamin C mega-doses and ionic Zinc for use in COVID-19 prevention
  4. Identify current alternative therapies with evidence of antiviral activity that may be helpful to prevent infection of COVID-19
  5. Differentiate and categorize alternative therapies with evidence from those that have no evidence and/or are unsafe

Speaker(s)/Author(s)

Michaela Almgren, PharmD, MS
Clinical Assistant Professor, University of South Carolina College of Pharmacy

Activity Number

0062-9999-20-188-L01-T
Date: 10/08/20
Time: 02:00 PM - 03:00 PM

CE Hours

1.00
 

 

At the completion of this activity, the participant will be able to:
  1. Describe the growth of women in pharmacy over the past 50 years
  2. Compare and contrast the reasons for the growth of women in pharmacy
  3. Discuss the areas of growth for women in pharmacy
 

Speaker(s)/Author(s)

Suzy Soliman, PharmD, BCMAS
Founder, Pharmacist Moms Group (PhMG)

Activity Number

0062-9999-20-189-L04-T
Date: 10/08/20
Time: 03:30 PM - 04:30 PM

CE Hours

1.00
 

 

At the completion of this activity, the participant will be able to:
  1. Describe the clinical presentation and long-term complications associated with sickle cell disease
  2. Identify newly FDA approved therapies for the management of sickle cell disease
  3. Compare and contrast the adverse effect profiles for various medications approved for the management of sickle cell disease

 

Speaker(s)/Author(s)

Courtney Alexander, PharmD, BCPS, BCOP
Assistant Professor, Auburn University Harrison School of Pharmacy

Activity Number

0062-9999-20-190-L01-T
Date: 10/08/20
Time: 06:00 PM - 07:00 PM

CE Hours

1.00
 

 

At the completion of this activity, the participant will be able to:
  1. Describe the risk of thromboembolic disease during active COVID-19 infection and the impact on morbidity and mortality
  2. Appraise current available evidence on the role of anticoagulation in preventing thromboembolism and improving outcomes in hospitalized and ambulatory COVID-19 patients
  3. Identify recent updates in guidelines and primary literature on the use of antithrombotic therapy in patients with thromboembolic disorders

Speaker(s)/Author(s)

Toby Trujillo, PharmD, FCCP, FAHA, BCPS-AQ Cardiology
Associate Professor, University of Colorado Skaggs School of Pharmacy and Pharmaceutical Sciences

Activity Number

0062-9999-20-191-L01-T
Date: 10/08/20
Time: 07:00 PM - 08:00 PM

CE Hours

1.00
 

 

 

At the completion of this activity, the participant will be able to:
  1. Describe the benefits and barriers to medications for OUD (MOUD)
  2. Determine custom treatment options for patients with OUD
  3. Select destigmatizing language to build trust and engage patients who may have OUD
  4. Educate patients on opioid overdose and prevention

Speaker(s)/Author(s)

Lauren Linder Weir, PharmD, BCPS, BCPP
Assistant Professor & SCORxE Clinical Pharmacy Consultant, MUSC College of Pharmacy

Activity Number

0062-9999-20-192-L08-T
Date: 10/09/20
Time: 02:00 PM - 03:00 PM

CE Hours

1.00
 

 

At the completion of this activity, the participant will be able to:
  1. Describe why developing diversity, equity and inclusion in pharmacy leadership is vital
  2. Define diversity, equity and inclusion
  3. Discuss tools to help develop diversity, equity and inclusion in pharmacy leadership

Speaker(s)/Author(s)

Aisha DeBerry, JD
Director of Diversity and Community Partnerships, Philadelphia College of Osteopathic Medicine

Edo-abasi McGee, PharmD, BCPS
Assistant Professor, Philadelphia College of Osteopathic Medicine School of Pharmacy

Jimmi Hatton Kolpek, PharmD, FCCP, FCCM, FNAP
Professor, University of Kentucky College of Pharmacy

Activity Number

0062-9999-20-193-L04-T
Date: 10/09/20
Time: 03:30 PM - 04:30 PM

CE Hours

1.00
 

 

At the completion of this activity, the participant will be able to:
  1. Recognize FDA-approved and non FDA-approved STI prevention/treatment regimens
  2. Compare consumer testimonials of STI prevention/treatment effectiveness on social media with those commonly reported in different healthcare settings
  3. Examine limitations of STI prevention/treatment advertisements featured among individuals with varying literacy levels

Speaker(s)/Author(s)

Kenric Ware, PharmD, MBA, AAHIVP
Assistant Professor of Pharmacy Practice, South University

Activity Number

0062-9999-20-194-L01-T
Date: 10/09/20
Time: 06:00 PM - 07:00 PM

CE Hours

1.00
 

 

At the completion of this activity, the participant will be able to:
  1. Identify the mechanisms of toxicity associated with beta blocker, calcium channel blocker, and cardioactive steroid ingestion
  2. Recall presenting signs and symptoms associated with toxic ingestions of cardioactive medications
  3. Recognize common antidotes for cardioactive drug overdoses
  4. Recognize dosing and concentration of common antidotes seen in cardioactive drug overdoses, particularly in relation to high dose insulin therapy

Speaker(s)/Author(s)

Charles “Trey” Wingerson III, PharmD
Assistant Professor, Presbyterian College School of Pharmacy

Activity Number

0062-9999-20-195-L01-T
Date: 10/09/20
Time: 07:00 PM - 08:00 PM

CE Hours

1.00